Serum CTRP5 is associated with in-stent restenosis after percutaneous coronary intervention

被引：0
|
作者：
Shen, Ying [1 ]
Pan, Chunyang [1 ]
Qiu, Jianping [1 ]
Lu, Lin [1 ]
Shen, Weifeng [1 ]
机构：
[1] Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200025, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2015.06.657
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW26-e5430
引用
收藏
页码：C172 / C172
页数：1
相关论文
共 50 条
  • [21] Percutaneous Interventions in Radiation-Associated Coronary In-Stent Restenosis
    P. Wexberg
    G. Beran
    I. Lang
    P. Siostrzonek
    C. Kirisits
    D. Glogar
    M. Gottsauner-Wolf
    CardioVascular and Interventional Radiology, 2003, 26 : 154 - 157
  • [22] In stent restenosis after percutaneous coronary intervention Reply
    Liu, Wenwei
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (01): : 73 - 74
  • [23] Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention
    Zheng, Guo-Hua
    Liu, Jian-Ping
    Wang, Nissi S.
    Chen, Hai-Ying
    Chu, Jian-Feng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [24] Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus
    Sukhija, Rishi
    Aronow, Wilbert S.
    Sureddi, Ravi
    Aleti, Sumith
    Molavi, Behzad
    Sachdeva, Rajesh
    Mehta, Jawahar L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (05): : 777 - 780
  • [25] Myocardial Injury after Percutaneous Coronary Intervention for In-Stent Restenosis Versus de novo Stenosis
    Shimonaga, Takashi
    Kurisu, Satoshi
    Watanabe, Noriaki
    Ikenaga, Hiroki
    Higaki, Tadanao
    Iwasaki, Toshitaka
    Ishibashi, Ken
    Dohi, Yoshihiro
    Fukuda, Yukihiro
    Kihara, Yasuki
    INTERNAL MEDICINE, 2015, 54 (18) : 2299 - 2305
  • [26] Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
    Lin, Xiao Long
    Li, Qiu Yu
    Zhao, Dong Hui
    Liu, Jing Hua
    Fan, Qian
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [27] An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
    Demyanets, Svitlana
    Tentzeris, Ioannis
    Jarai, Rudolf
    Katsaros, Katharina M.
    Farhan, Serdar
    Wonnerth, Anna
    Weiss, Thomas W.
    Wojta, Johann
    Speidl, Walter S.
    Huber, Kurt
    CYTOKINE, 2014, 67 (02) : 65 - 70
  • [28] High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention
    Takamori, N
    Azuma, H
    Kato, M
    Hashizume, S
    Aihara, K
    Akaike, M
    Tamura, K
    Matsumoto, T
    CIRCULATION, 2004, 109 (04) : 481 - 486
  • [29] Abciximab administration and clinical outcomes after percutaneous intervention for in-stent restenosis
    Moustapha, A
    Assali, AR
    Sdringola, S
    Yusuf, SW
    Vaughn, WK
    Fish, RD
    Schroth, GW
    Krajcer, Z
    Rosales, OR
    Smalling, RW
    Anderson, HV
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2002, 56 (02) : 184 - 187
  • [30] Serum Free Indoxyl Sulfate Associated with In-stent Restenosis After Coronary Artery Stentings
    Tsai, Ming-Lung
    Hsieh, I-Chang
    Hung, Cheng-Chieh
    Chen, Chun-Chi
    CARDIOVASCULAR TOXICOLOGY, 2015, 15 (01) : 52 - 60
12345